Biomarkers for Personalized Oncology and Precision Immunotherapy
This track focuses on the critical role of biomarkers in tailoring oncology treatments and guiding immunotherapy. Presentations will showcase how genetic mutations, protein expression, and immune signatures influence therapeutic responses. Attendees will learn about biomarker applications in checkpoint inhibition, adoptive cell therapy, and cancer vaccines. The session will also cover real-time biomarker monitoring for therapy resistance and relapse detection.
Further discussions will address the integration of multi-omics and imaging biomarkers to optimize personalized oncology care. Experts will share case studies demonstrating improved patient outcomes through biomarker-guided immunotherapy. Participants will understand how biomarker science continues to drive precision oncology forward, bridging clinical innovation with patient-centered treatment strategies.